ThinkCyte Introduces MorphoScan Cloud for AI-Driven Cell Analysis
ThinkCyte has announced the pre-commercial launch of MorphoScan Cloud, a versatile cloud-based platform for AI-driven cell morphology data analysis, announced in a press release. The launch was made at the 38th Annual Congress of the International Society for the Advancement of Cytometry (CYTO 2025) in Denver, Colorado.
MorphoScan Cloud is designed to enhance the user experience for customers of VisionSort, ThinkCyte's flagship morphometric cell analysis and sorting platform. It offers secure cloud storage and multi-user access, enabling research teams to centralize, share, and analyze data more efficiently. The platform integrates advanced analytical tools to unlock deeper biological insights from complex cellular data using both supervised and unsupervised learning techniques.
Waichiro Katsuda, CEO of ThinkCyte, stated that MorphoScan Cloud provides an intelligent platform that transforms how research teams engage with cellular data. By combining VisionSort's biological insights with AI's analytical power and cloud accessibility, the platform aims to streamline data analysis workflows and accelerate discovery in life sciences.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 22 BioStack Raises $9.5 Million for Medical AI Data Network Oct 22 Warp Sciences Raises $215 Million to Automate Drug Discovery Labs Oct 22 FDA Clears RIVANNA BoneEnhance Software for Accuro XV Oct 22 Tufts Medicine Uses Humata Health to Automate Prior Authorization Oct 22 HHS Plans Sole Source Claude Contract With AnthropicLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Illumina Launches BioInsight Platform for Genomic Research
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Illumina Adds Three Research Tools to BioInsight Platform
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Cyient launches CYiNGINE for AI based lifecycle engineering
Daily AI Brief: the AI news that matters, in your inbox.